PCSK9 genetic variants and cognitive abilities: a large-scale Mendelian randomization study.

Conclusions: We are unable to rule out meaningful associations of PCSK9 genetic variants with cognition, emphasising the potential need for continued pharmacovigilance for patients currently treated with PCSK9 inhibitors. PMID: 33488877 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/33488877?dopt=Abstract

Source: Archives of Medical Science - January 27, 2021 Category: Biomedical Science Tags: Arch Med Sci Source Type: research